Kenneth M. Kral

2.1k total citations
17 papers, 700 citations indexed

About

Kenneth M. Kral is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Kenneth M. Kral has authored 17 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology and Allergy. Recurrent topics in Kenneth M. Kral's work include Asthma and respiratory diseases (15 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (6 papers). Kenneth M. Kral is often cited by papers focused on Asthma and respiratory diseases (15 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (6 papers). Kenneth M. Kral collaborates with scholars based in United States, United Kingdom and India. Kenneth M. Kral's co-authors include Ibrahim Raphiou, David A. Stempel, Steven R. Findlay, Steven Pascoe, Anne Yeakey, Barbara A. Prillaman, Charlene M. Prazma, Paul H. Ratner, Kathleen Rickard and Steven W. Yancey and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PEDIATRICS.

In The Last Decade

Kenneth M. Kral

16 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth M. Kral United States 13 592 483 282 39 34 17 700
Hubert Méchin France 8 325 0.5× 101 0.2× 327 1.2× 94 2.4× 14 0.4× 17 504
Irving W. Schiller United States 13 156 0.3× 241 0.5× 61 0.2× 40 1.0× 8 0.2× 36 471
Austin Carmichael United Kingdom 7 31 0.1× 34 0.1× 89 0.3× 198 5.1× 23 0.7× 13 309
A. Manon Brenner United States 7 187 0.3× 181 0.4× 15 0.1× 3 0.1× 9 0.3× 12 336
Francesco Stefanelli Italy 10 169 0.3× 252 0.5× 7 0.0× 1 0.0× 2 0.1× 18 502
Lorenza Matarazzo Italy 8 39 0.1× 18 0.0× 68 0.2× 11 0.3× 3 0.1× 23 231
Laurence Girard France 7 47 0.1× 21 0.0× 13 0.0× 13 0.3× 50 1.5× 12 196
Timothy Wright Australia 9 71 0.1× 213 0.4× 4 0.0× 8 0.2× 16 0.5× 22 460
Umar Amin Qureshi India 12 54 0.1× 68 0.1× 6 0.0× 5 0.1× 21 0.6× 22 365
Gregory S. Montgomery United States 10 81 0.1× 349 0.7× 6 0.0× 8 0.2× 27 489

Countries citing papers authored by Kenneth M. Kral

Since Specialization
Citations

This map shows the geographic impact of Kenneth M. Kral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth M. Kral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth M. Kral more than expected).

Fields of papers citing papers by Kenneth M. Kral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth M. Kral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth M. Kral. The network helps show where Kenneth M. Kral may publish in the future.

Co-authorship network of co-authors of Kenneth M. Kral

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth M. Kral. A scholar is included among the top collaborators of Kenneth M. Kral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth M. Kral. Kenneth M. Kral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Szefler, Stanley J., Ibrahim Raphiou, Robert S. Zeiger, et al.. (2019). Seasonal variation in asthma exacerbations in the AUSTRI and VESTRI studies. ERJ Open Research. 5(2). 153–2018. 13 indexed citations
2.
Stempel, David A., Ibrahim Raphiou, Kenneth M. Kral, et al.. (2016). Austri, a Large Randomized Study in Adolescents and Adults with Asthma, Assessing the Safety and Efficacy of Salmeterol in Combination with Fluticasone Propionate Compared to Fluticasone Propionate Alone. Journal of Allergy and Clinical Immunology. 137(2). AB389–AB389. 2 indexed citations
3.
Stempel, David A., Stanley J. Szefler, Søren Pedersen, et al.. (2016). Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma. New England Journal of Medicine. 375(9). 840–849. 77 indexed citations
4.
Stempel, David A., Ibrahim Raphiou, Kenneth M. Kral, et al.. (2016). Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone. New England Journal of Medicine. 374(19). 1822–1830. 104 indexed citations
5.
Stempel, David A., Stanley J. Szefler, Søren Pedersen, et al.. (2016). LATE-BREAKING ABSTRACT: Safety of salmeterol/fluticasone propionate (FSC) compared to fluticasone propionate (FP) in 4-17 yr olds with asthma. OA4798–OA4798. 1 indexed citations
6.
Prazma, Charlene M., et al.. (2010). Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections. Respiratory Medicine. 104(6). 780–787. 13 indexed citations
7.
Badesch, David B., Michael D. McGoon, Victor F. Tapson, et al.. (2009). Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol. The Journal of Rheumatology. 36(10). 2244–2249. 59 indexed citations
8.
Bateman, Eric D., Harold S. Nelson, Jean Bousquet, et al.. (2008). Meta-analysis: Effects of Adding Salmeterol to Inhaled Corticosteroids on Serious Asthma-Related Events. Annals of Internal Medicine. 149(1). 33–42. 78 indexed citations
9.
Allen, David B., Eli O. Meltzer, Robert F. Lemanske, et al.. (2003). No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year.. PubMed. 23(6). 407–13. 92 indexed citations
10.
Knobil, Katharine, Steven W. Yancey, Kenneth M. Kral, & Kathleen Rickard. (2003). Salmeterol Multi-center Asthma Research Trial (SMART): Results From an Interim Analysi. CHEST Journal. 124(4). 335S–335S. 12 indexed citations
11.
Vargas, Ramón, Robert J. Dockhorn, Steven R. Findlay, et al.. (1999). Reply. Journal of Allergy and Clinical Immunology. 103(3). 537–538.
12.
Vargas, Ramón, Robert J. Dockhorn, Steven R. Findlay, et al.. (1998). Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis. Journal of Allergy and Clinical Immunology. 102(2). 191–197. 46 indexed citations
13.
Wasserman, Stephen I., Gary N. Gross, William F. Schoenwetter, et al.. (1996). A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of Asthma. Journal of Asthma. 33(4). 265–274. 59 indexed citations
14.
Munk, Zev M., David S. Pearlman, David F. Graft, et al.. (1994). Intranasal Fluticasone Propionate Is Effective and Well-Tolerated in Adolescents with Seasonal Allergic Rhinitis. Pediatric Asthma Allergy & Immunology. 8(1). 39–46. 13 indexed citations
15.
Grossman, Jay, Charles H. Banov, Edwin A. Bronsky, et al.. (1993). Fluticasone Propionate Aqueous Nasal Spray Is Safe and Effective for Children With Seasonal Allergic Rhinitis. PEDIATRICS. 92(4). 594–599. 60 indexed citations
16.
Ratner, Paul H., Barry R. Paull, Steven R. Findlay, et al.. (1992). Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily. Journal of Allergy and Clinical Immunology. 90(3). 285–291. 69 indexed citations
17.
Kalsbeek, William D., Kenneth M. Kral, Robert B. Wallace, & Basil M. Rifkind. (1988). COMPARING MEAN LEVELS OF TOTAL CHOLESTEROL FROM VISIT 2 OF THE LIPID RESEARCH CLINICS PREVALENCE STUDY WITH THE SECOND NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY. American Journal of Epidemiology. 128(5). 1038–1053. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hubert Méchin Breakdown of academic impact, for papers by Irving W. Schiller Breakdown of academic impact, for papers by Austin Carmichael Breakdown of academic impact, for papers by A. Manon Brenner Breakdown of academic impact, for papers by Francesco Stefanelli Breakdown of academic impact, for papers by Lorenza Matarazzo Breakdown of academic impact, for papers by Laurence Girard Breakdown of academic impact, for papers by Timothy Wright Breakdown of academic impact, for papers by Umar Amin Qureshi Breakdown of academic impact, for papers by Gregory S. Montgomery
Rankless by CCL
2026